Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists
Matthew J. Klebanoff, Pengxiang Li, Judith Long, Jalpa A. Doshi
Abstract
This cross-sectional study examines Medicare Part D coverage and out-of-pocket costs for glucagon-like peptide-1 receptor agonists following implementation of the Inflation Reduction Act.
Topics & Concepts
MedicineMedicare Part DAgonistReceptorReduction (mathematics)Intensive care medicineMEDLINEActuarial scienceInternal medicineInflation (cosmology)Cost controlPharmacologyMedication Adherence and CompliancePharmaceutical studies and practicesHeart Failure Treatment and Management